Involvement of PKA and Sp1 in the induction of p27(Kip1) by tamoxifen (Q44541997)

4 December 2017

title

Involvement of PKA and Sp1 in the induction of p27(Kip1) by tamoxifen (English)

1 reference

4 December 2017

1 reference

Te-Hsiu Lee

1

1 reference

4 December 2017

Hui-Chiu Chang

series ordinal

2

1 reference

4 December 2017

Lea-Yea Chuang

series ordinal

3

1 reference

4 December 2017

Wen-Chun Hung

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

4 December 2017

published in

Biochemical Pharmacology

1 reference

4 December 2017

volume

66

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

371-377

1 reference

Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Hormonal chemoprevention of cancer in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

A cell cycle-regulated inhibitor of cyclin-dependent kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Cyclin E-CDK2 is a regulator of p27Kip1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Molecular cloning and characterization of the human p27Kip1 gene promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Translational control of p27Kip1 accumulation during the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

The ubiquitous transcription factor NF-Y positively regulates the transcription of human p27Kip1 through a CCAAT box located in the 5-upstream region of the p27Kip1 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Modulation of transcription factor Sp1 by cAMP-dependent protein kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900258-2

10.1016/S0006-2952(03)00258-2

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference